Yousef, Bashir A <br/><br/>
Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.  [electronic resource] 

 -  Oncology reports  Feb 2016 
 - 1091-100 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2015.4457  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Antineoplastic Agents, Phytogenic--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--biosynthesis<br/>Cell Cycle Proteins--biosynthesis<br/>Cell Line, Tumor<br/>Colorectal Neoplasms--pathology<br/>Drug Screening Assays, Antitumor<br/>G1 Phase--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--biosynthesis<br/>Membrane Potential, Mitochondrial--drug effects<br/>Neoplasm Proteins--biosynthesis<br/>Pentacyclic Triterpenes<br/>Signal Transduction--drug effects<br/>Triterpenes--pharmacology